the withdrawal was a commercial decision
Participants in the Retatrutide Triumph trial are losing close to 30% of their weight, among many other health benefits While Retatrutide is NOT approved by the FDA, it is available under a "research only" provision from many companies
The connection between decreased liver fat and changes in -hydroxybutyrate at 24 weeks implies retatrutide could assist the body in burning fat more efficiently for fuel
By-products of cellular metabolism are also free radicals that are destructive
Armstrong JS, Whiteman M, Yang H, Jones DP, Sternberg Jr P
For now, GLP-1s are reshaping the conversationbetween researchers, clinicians and patients alike